Finasteride Dose for Hair Thinning
For adult males with androgenetic alopecia (male pattern hair loss), the recommended dose is oral finasteride 1 mg once daily. 1
Dosing Rationale
The FDA-approved dose for hair loss is 1 mg daily, which differs from the 5 mg daily dose used for benign prostatic hyperplasia. 1
Dose-ranging studies established 1 mg as the optimal dose by demonstrating that 1 mg and 5 mg showed similar efficacy for hair regrowth, both superior to lower doses (0.2 mg and 0.01 mg), making the 1 mg dose preferable due to equivalent efficacy with lower drug exposure. 2
The medication can be taken with or without food, providing flexibility for patient adherence. 1
Expected Efficacy and Timeline
Clinically significant hair count increases occur within 1-2 years, with studies showing an increase of 107-138 hairs (measured in a 1-inch diameter area) compared to progressive hair loss with placebo. 3
Long-term data demonstrates sustained benefit for up to 5 years, with durable improvements in scalp hair growth and continued slowing of hair loss progression throughout treatment. 4
Approximately 92% of patients achieve stable or improved outcomes when assessed over 12 months, with 57% showing marked improvements. 5
Maximum DHT suppression occurs 8 hours after dosing, with approximately 70% reduction in serum DHT maintained throughout the 24-hour dosing interval with daily administration. 1
Topical Alternatives
Topical finasteride 0.25% applied once daily (evening) represents an alternative for patients concerned about systemic effects, though it produces less marked decreases in serum DHT compared to oral administration. 6
Combination therapy with topical finasteride 0.25% plus minoxidil 5% shows superior efficacy compared to either monotherapy, with 79% of patients achieving significant improvement versus 8% with finasteride alone and 41% with minoxidil alone at 6 months. 7, 8
Safety Considerations
Sexual adverse effects are the primary concern, including decreased libido (occurring in approximately 4-10% vs 1-6% with placebo), erectile dysfunction, and decreased ejaculate volume, though these remain within acceptable ranges in clinical trials. 9
Gynecomastia occurs in approximately 2-4% of treated patients compared to 0.7-2.8% with placebo. 9
Hormonal effects are minimal: testosterone levels increase by approximately 10-20% but remain within physiologic range, and the hypothalamic-pituitary-testicular axis remains unaffected. 1
Discontinuation results in return to baseline within approximately 2 weeks for DHT levels and 3 months for prostate volume, indicating reversibility of effects. 1
Common Pitfalls to Avoid
Do not use the 5 mg BPH dose for hair loss, as the 1 mg dose provides equivalent hair regrowth efficacy with lower drug exposure. 2
Counsel patients that improvement takes time: visible results typically require 3-6 months of continuous treatment, and stopping therapy results in reversal of benefits. 4, 3
Address sexual side effect concerns proactively: while these effects occur more frequently than placebo in trials, the absolute rates remain relatively low (4-10% range), and frank discussion improves adherence. 9